Alaunos Therapeutics Total Liabilities

Alaunos Therapeutics (TCRT) currently reports a total liabilities of $860K as of June 2026. That compares with $1.1M in the prior-year period — down 19.6% year over year. Use the charts on this page to explore Alaunos Therapeutics's total liabilities history and peer comparisons.

Alaunos Therapeutics's total liabilities decreased from $1.1M to $860K — a 19.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Alaunos Therapeutics reported $860K in total liabilities as of June 2026. That compares with $1.1M in the prior-year period — down 19.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $860K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Alaunos Therapeutics, and consider following TCRT for alerts when major investors trade the stock.

Alaunos Therapeutics is classified in the Healthcare sector. On total liabilities, it currently shows $860K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TCRT with unrelated industries.